Predict your next investment

Corporation
HEALTHCARE | Medical Facilities & Services / Medical Practice Management & Services
iorahealth.com

See what CB Insights has to offer

Executives

8

Board of Directors

5

Iora Health Board of Directors

5 Board of directors

Iora Health has 5 board of directors, including Liam Donohue.

Name

Firm

Work History

Other Seats

Liam Donohue

Mr. Donohue is a co-founder and General Partner of .406 Ventures, a Boston-based venture capital firm. Prior, Mr. Donohue was a founding General Partner of Arcadia Partners, a fund focused on investments in tech-enabled education companies and a founding investor in BIA. Mr. Donohue has also served as a Principal at Foster Management Company and as a Director for Booz Allen Hamilton. Mr. Donohue holds a BS in Chemistry from Georgetown University and an MBA from Dartmouth’s Amos Tuck School of Business.

Iora Health

Liam Donohue

Mr. Donohue is a founding partner of Arcadia. He is currently a director of Health Dialog, Knowledge Impact, KnowledgePlanet and Access Worldwide and Chairman of Business Intelligence Advisors. He is also on the Board of Advisors of Dartmouth&Atilde;&macr;&Acirc;&iquest;&Acirc;&frac12;s Tuck Center for Private Equity. </br></br>Prior to founding Arcadia, Mr. Donohue was a Principal of Foster Management Company, a private equity firm specializing in consolidating fragmented service industries undergoing structural change. At Foster Management, Mr. Donohue was responsible for all aspects of the investment process, including: selecting attractive industries and niches in which to invest

Iora Health

Stephen Knight

Stephen Knight joined F-Prime Capital in 2003 where he serves as President and Managing Partner. He has worked in the pharmaceutical and biotechnology industries for over 25 years and invests broadly across healthcare. Dr. Knight also serves on the board of directors of Atalanta Therapeutics, Beam Therapeutics (NASDAQ: BEAM), Ensoma, Geneception, Genomics plc, Iora Health, Leyden Labs, Pulmocide and Sana Biotechnology. Prior to joining F-Prime Capital, he held various senior management roles in private and public biotechnology and consulting companies. Dr. Knight was also a researcher at AT&T Bell Laboratories, the National Institutes of Health and Yale University. He holds an M.D. from the Yale University School of Medicine, an M.B.A. from the Yale School of Organization and Management and received a B.S. in biology from Columbia University, graduating summa cum laude and Phi Beta Kappa.

Iora Health

Terrance McGuire

Iora Health

Tim Howe

Iora Health

Name

Liam Donohue

Liam Donohue

Stephen Knight

Terrance McGuire

Tim Howe

Firm

Work History

Mr. Donohue is a co-founder and General Partner of .406 Ventures, a Boston-based venture capital firm. Prior, Mr. Donohue was a founding General Partner of Arcadia Partners, a fund focused on investments in tech-enabled education companies and a founding investor in BIA. Mr. Donohue has also served as a Principal at Foster Management Company and as a Director for Booz Allen Hamilton. Mr. Donohue holds a BS in Chemistry from Georgetown University and an MBA from Dartmouth’s Amos Tuck School of Business.

Mr. Donohue is a founding partner of Arcadia. He is currently a director of Health Dialog, Knowledge Impact, KnowledgePlanet and Access Worldwide and Chairman of Business Intelligence Advisors. He is also on the Board of Advisors of Dartmouth&Atilde;&macr;&Acirc;&iquest;&Acirc;&frac12;s Tuck Center for Private Equity. </br></br>Prior to founding Arcadia, Mr. Donohue was a Principal of Foster Management Company, a private equity firm specializing in consolidating fragmented service industries undergoing structural change. At Foster Management, Mr. Donohue was responsible for all aspects of the investment process, including: selecting attractive industries and niches in which to invest

Stephen Knight joined F-Prime Capital in 2003 where he serves as President and Managing Partner. He has worked in the pharmaceutical and biotechnology industries for over 25 years and invests broadly across healthcare. Dr. Knight also serves on the board of directors of Atalanta Therapeutics, Beam Therapeutics (NASDAQ: BEAM), Ensoma, Geneception, Genomics plc, Iora Health, Leyden Labs, Pulmocide and Sana Biotechnology. Prior to joining F-Prime Capital, he held various senior management roles in private and public biotechnology and consulting companies. Dr. Knight was also a researcher at AT&T Bell Laboratories, the National Institutes of Health and Yale University. He holds an M.D. from the Yale University School of Medicine, an M.B.A. from the Yale School of Organization and Management and received a B.S. in biology from Columbia University, graduating summa cum laude and Phi Beta Kappa.

Other Seats

Iora Health

Iora Health

Iora Health

Iora Health

Iora Health

Iora Health Management Team

8 Team Members

Iora Health has 8 executives. Iora Health's current President is Alexander Packard.

Name

Work History

Title

Status

Alexander Packard

President

Current

Suzanne Tinder Hansen

Chief Operating Officer

Current

Tyler Jung

DaVita HealthCare Partners, and HealthCare Partners

Chief Medical Officer

Current

Clark Curtis

Senior Vice President

Current

Neil Patel

Freelancers Union, and Boston University

Senior Vice President

Current

Name

Alexander Packard

Suzanne Tinder Hansen

Tyler Jung

Clark Curtis

Neil Patel

Work History

DaVita HealthCare Partners, and HealthCare Partners

Freelancers Union, and Boston University

Title

President

Chief Operating Officer

Chief Medical Officer

Senior Vice President

Senior Vice President

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.